API australian pharmaceutical industries limited

Ann: FY20 Results - Media Release, page-3

  1. 1,157 Posts.
    lightbulb Created with Sketch. 185
    Disagree. "one would have to look at the cash flow statement"... Yep, agree, maybe take your own advice next time.

    A couple of points for you to consider:

    Income statement - What caused the -$87k reduction in NPAT?
    - Gross profit -$43k - Given store closures I dont see how you can't blame this on Covid
    - Administration fees +20k - Please explain warranted
    -
    One off impairment (Soul Pattisson Chemists) +37k - Please explain warranted but this is a non-cash expense.

    Cash Flow Statement

    As a shareholder, how can you be dissapointed with a $180k increase in cash inflows from operations AND net cashflows from operations increasing by $204k.

    Considering the broader economic landscape, this is a great result IMO. Yes there are clear improvements from management that are required (for one, shareholder comms are appauling), however I am liking what I see from a cash generation perspective.
    https://hotcopper.com.au/data/attachments/2586/2586328-9a11a4e30aaaf46fde223547513f7860.jpg
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.